WS #10174
US launches Section 301 investigation into Germany's drug pricing policies, targeting pharmaceutical imports and potentially impacting German pharma stocks.
US tariff probe on German pharma
US launches Section 301 investigation into Germany's drug pricing policies, targeting pharmaceutical imports and potentially impacting German pharma stocks.